Chang G T, Aaldering L, Hackeng T M, Reitsma P H, Bertina R M, Bouma B N
Department of Haematology, University Hospital Utrecht, The Netherlands.
Thromb Haemost. 1994 Nov;72(5):693-7.
Protein S is a vitamin K-dependent plasma protein that functions as a cofactor of activated protein C (APC) in the inactivation of coagulation factors Va and VIIIa. Protein S, migrates as a doublet on reduced SDS polyacrylamide gel electrophoresis. This heterogeneity in molecular weight has been explained by limited proteolysis of protein S. Human protein S contains at Arg-49, Arg-60 and Arg-70 three potential cleavage sites. Whether cleavage occurs at all three sites is not known. To study the role of these arginine residues in human protein S, we have replaced them by leucine or isoleucine. All seven possible variants were constructed: three variants with single mutations (R49L, R60L, R70I), three variants with double mutations (R49L/R60L, R60L/R70I, R49L/R70I) and one variant with a triple mutation (R49L/R60L/R70I). On reduced SDS polyacrylamide gels the single and double variants migrate as a doublet just like the wild type protein S. The triple variant migrates as a single band at a molecular weight corresponding to the upper band of the doublet. The upper band of the single and double variants but not of the triple variant could be converted into the lower band by thrombin treatment. All variants showed cofactor activity to APC in a clotting assay. After thrombin treatment, this cofactor activity was abolished for the single (R49L, R60L, R70I) and double variants (R49L/R60L, R60L/R70I, R49L/R70I), while the triple variant (R49L/R60L/R70I) tested at several concentrations, retained its cofactor activity completely, suggesting resistance to thrombin. This shows that thrombin can cleave at all three arginine sites and that cleavage at each of these sites results in the loss of APC cofactor activity.(ABSTRACT TRUNCATED AT 250 WORDS)
蛋白S是一种维生素K依赖的血浆蛋白,在凝血因子Va和VIIIa的失活过程中作为活化蛋白C(APC)的辅因子发挥作用。蛋白S在还原型SDS聚丙烯酰胺凝胶电泳上呈现为双峰。分子量的这种异质性已通过蛋白S的有限蛋白水解得到解释。人蛋白S在Arg-49、Arg-60和Arg-70处含有三个潜在的切割位点。是否在所有三个位点都发生切割尚不清楚。为了研究这些精氨酸残基在人蛋白S中的作用,我们将它们替换为亮氨酸或异亮氨酸。构建了所有七种可能的变体:三种单突变变体(R49L、R60L、R70I)、三种双突变变体(R49L/R60L、R60L/R70I、R49L/R70I)和一种三突变变体(R49L/R60L/R70I)。在还原型SDS聚丙烯酰胺凝胶上,单突变和双突变变体与野生型蛋白S一样呈现为双峰。三突变变体在对应于双峰上带的分子量处迁移为单一条带。单突变和双突变变体的上带而非三突变变体的上带可通过凝血酶处理转化为下带。在凝血试验中,所有变体对APC均显示出辅因子活性。凝血酶处理后,单突变(R49L、R60L、R70I)和双突变变体(R49L/R60L、R60L/R70I、R49L/R70I)的这种辅因子活性被消除,而在几个浓度下测试的三突变变体(R49L/R60L/R70I)完全保留了其辅因子活性,表明对凝血酶具有抗性。这表明凝血酶可在所有三个精氨酸位点进行切割,并且在这些位点中的每一个位点进行切割都会导致APC辅因子活性丧失。(摘要截短至250字)